Clinical Trial Update: Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating a combination of abiraterone acetate, prednisone, and apalutamide in men with hormone-naive metastatic prostate cance…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ERLEADA (apalutamide)
• PREDNISONE (Prednisone)
• Zytiga (abiraterone acetate)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Prostate Carcinoma, Prostate Adenocarcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING